firms that focus primarily on the manufacturing and selling of medical devices. Masimo and
Thoratec, both headquartered in the United States, have global operations and sell to hospitals
and clinical sites around the world. Both companies were founded in the 1970-80s with a key
mission of creating rivaled products that will help patients with their health. Though they have
key similarities, the disparities between these two companies are apparent, which will lead
them to prosper in the future. They will both continue to improve, paving the way for incredible
product innovation.
History and Strategy of Masimo & Thoratec:
Masimo Corporation is a medical device company that specializes in non-invasive
patient monitory products, meaning they create products that do not pierce skin, and gets
results from external monitoring. Founded in 1989 by current Chief Executive Officer, Joe Kiani,
Masimo strives to use adaptive signal processing. Key principles and strategies implemented by
Masimo is foremost patient-first. They try and create products to minimize unwarranted
patient deaths and improve lives of both the older population as well as the growing new-born
demographic. Through different product strategies, such as products geared towards
hemoglobin count, or products for monitoring patient hearts and heart detection monitory,
Masimo Corporation is a leader in the field.
Thoratec Corporation is also another company that specializes in medical
technology. The company was found in March of 1976, and subsequently went public 5 years
later in the Spring of 2014. Thoratec’s current executives include Gary F. Burbach (CEO), David
A. Lehman (General Counsel), and Taylor Harris (CFO). Thoratec merged with Thermo
Cardiosystems in February 2001, making it a world leader in the circulatory support space. The
products are geared towards saving, supporting, and restoring